
JAMP Pharma Group Launches PrJAMP Teriflunomide, a New Generic for the Treatment of Patients with Relapsing-Remitting Multiple Sclerosis
JAMP Pharma Group, leading the volume of prescriptions in Quebec for a third consecutive year1, launches Teriflunomide, a complex generic, offering a more affordable alternative to PrAubagio® (Sanofi). JAMP Pharma Group expands its range of specialty products, thus contributing to its ambition to offer healthcare professionals and patients services adapted…
New launches, Press release